Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.
Sixfold Bioscience's investors include Y Combinator, Cantos, Bossa Invest, Innovate UK, European Commission.
Sixfold Bioscience is headquartered in London, United Kingdom.
Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.
Sixfold Bioscience is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sixfold Bioscience — Funding & Investors." VCBacked, December 2, 2021, https://www.vcbacked.co/company/sixfold-bioscience. Accessed August 13, 2026.
VCBacked. (2021). Sixfold Bioscience — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/sixfold-bioscience
{{cite web |title=Sixfold Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/sixfold-bioscience |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated